SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+0.17%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$233M
AUM Growth
+$233M
(+9.4%)
Cap. Flow
+$21.4M
Cap. Flow
% of AUM
9.18%
Top 10 Holdings %
Top 10 Hldgs %
39.53%
Holding
45
New
6
Increased
12
Reduced
9
Closed
5
Top Buys
| 1 |
Merck
MRK
|
$7.98M |
| 2 |
AbbVie
ABBV
|
$6.38M |
| 3 |
Medtronic
MDT
|
$5.44M |
| 4 |
Humana
HUM
|
$4.61M |
| 5 |
UnitedHealth
UNH
|
$4.49M |
Top Sells
| 1 |
Stryker
SYK
|
$2.85M |
| 2 |
Revvity
RVTY
|
$2.8M |
| 3 |
Globus Medical
GMED
|
$2.8M |
| 4 |
Johnson & Johnson
JNJ
|
$2.65M |
| 5 |
Moderna
MRNA
|
$2.34M |
Sector Composition
| 1 | Healthcare | 93.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Elevance Health
ELV
$71.8B
| $4.85M | 2.08% |
10,543
+2,543
| +32% | +$1.17M |
|
27
Vertex Pharmaceuticals
VRTX
$100B
| $4.73M | 2.03% |
15,000
| – | – |
|
28
Waters Corp
WAT
$18B
| $4.64M | 2% |
15,000
| – | – |
|
29
Abbott
ABT
$231B
| $4.56M | 1.96% |
45,000
| – | – |
|
30
IQVIA
IQV
$32.4B
| $3.98M | 1.71% |
20,000
+5,000
| +33% | +$995K |
|
31
Cigna
CI
$80.3B
| $3.83M | 1.65% |
15,000
-5,000
| -25% | -$1.28M |
|
32
Becton Dickinson
BDX
$55.3B
| $3.71M | 1.6% |
+15,000
| New | +$3.71M |
|
|
SGEN
33
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.24M | 1.39% |
16,000
+3,000
| +23% | +$608K |
|
34
Icon
ICLR
$13.8B
| $3.2M | 1.38% |
15,000
| – | – |
|
35
Encompass Health
EHC
$12.3B
| $2.98M | 1.28% |
55,000
-30,000
| -35% | -$1.62M |
|
36
Select Medical
SEM
$1.61B
| $2.79M | 1.2% |
107,838
+7,838
| +8% | +$203K |
|
37
Biogen
BIIB
$19.4B
| $2.78M | 1.2% |
10,000
| – | – |
|
38
Option Care Health
OPCH
$4.65B
| $2.54M | 1.09% |
80,000
-50,000
| -38% | -$1.59M |
|
39
Sarepta Therapeutics
SRPT
$1.78B
| $1.79M | 0.77% |
+13,000
| New | +$1.79M |
|
40
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.5M | 0.65% |
+7,500
| New | +$1.5M |
|
41
BioNTech
BNTX
$24B
| – | – |
-13,000
| Closed | -$1.95M |
|
|
42
Globus Medical
GMED
$8.27B
| – | – |
-37,745
| Closed | -$2.8M |
|
|
43
Johnson & Johnson
JNJ
$427B
| – | – |
-15,000
| Closed | -$2.65M |
|
|
44
Moderna
MRNA
$9.37B
| – | – |
-13,000
| Closed | -$2.34M |
|
|
45
Revvity
RVTY
$10.5B
| – | – |
-20,000
| Closed | -$2.8M |
|